Is prevalence of PBC underestimated in patients with systemic sclerosis?

Digestive and Liver Disease

Volumn 41, Issue 10, 2009, Pages 762-764

  Norman, G L ^a   Bialek, A ^b   Encabo, S ^a   Butkiewicz, B ^b   Wiechowska Kozlowska, A ^b   Brzosko, M ^b   Shums, Z ^a   Milkiewicz, P ^b  

^a INOVA DIAGNOSTICS INC   (United States)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Primary biliary cirrhosis (PBC); Systemic sclerosis (SSc)

Indexed keywords

AUTOANTIBODY; CENTROMERE ANTIBODY; F ACTIN; GLYCOPROTEIN GP 210; JO 1 ANTIBODY; MITOCHONDRION ANTIBODY; RNA POLYMERASE II; RO 52 ANTIBODY; RO 60 ANTIBODY; RO ANTIBODY; SCL 70 ANTIBODY; SOLUBLE LIVER ANTIGEN; SP100 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC SCLEROSIS;

ANTIGENS, NUCLEAR; AUTOANTIBODIES; AUTOANTIGENS; BIOLOGICAL MARKERS; COHORT STUDIES; COMORBIDITY; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA, LIVER; NUCLEAR PORE COMPLEX PROTEINS; PREVALENCE; SCLERODERMA, SYSTEMIC;

EID: 69749093722     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.01.014     Document Type: Article

References (15)

1. Leuschner U. Primary biliary cirrhosis-presentation and diagnosis. Clin Liver Dis 7 (2003) 741-758
2. Mitchison H.C., Bassendine M.F., Hendrick A., Bennett M.K., Bird G., Watson A.J., et al. Positive antimitochondrial antibody but normal alkaline phosphatase: is this primary biliary cirrhosis?. Hepatology 6 (1986) 1279-1284
3. Rigamonti C., Shand L.M., Feudjo M., Bunn C.C., Black C.M., Denton C.P., et al. Clinical features and prognosis of primary biliary cirrhosis associated with systemic sclerosis. Gut 55 (2006) 388-394
4. Corpechot C., Carrat F., Bahr A., Chretien Y., Poupon R.E., and Poupon R. The effect of ursodeoxycholic acid therapy on the natural course of primary biliary cirrhosis. Gastroenterology 128 (2005) 297-303
5. Moteki S., Leung P.S., Coppel R.L., Dickson E.R., Kaplan M.M., Munoz S., et al. Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies. Hepatology 24 (1996) 97-103
6. Worman H.J., and Courvalin J.C. Antinuclear antibodies specific for primary biliary cirrhosis. Autoimmun Rev 2 (2003) 211-217
7. Zuchner D., Sternsdorf T., Szostecki C., Heathcote E.J., Cauch-Dudek K., and Will H. Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis. Hepatology 26 (1997) 1123-1130
8. Itoh S., Ichida T., Yoshida T., Hayakawa A., Uchida M., Tashiro-Itoh T., et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 13 (1998) 257-265
9. Caramaschi P., Biasi D., Volpe A., Carletto A., Cecchetto M., and Bambara L.M. Coexistence of systemic sclerosis with other autoimmune diseases. Rheumatol Int 27 (2007) 407-410
10. Watt F.E., James O.F., and Jones D.E. Patterns of autoimmunity in primary biliary cirrhosis patients and their families: a population-based cohort study. Q J Med 97 (2004) 397-406
11. Muratori P., Muratori L., and Gershwin M.E. 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both?. Clin Exp Immunol 135 (2004) 154-158
12. Vergani D., and Bogdanos D.P. Positive markers in AMA-negative PBC. Am J Gastroenterol 98 (2003) 241-243
13. Metcalf J.V., Mitchison H.C., Palmer J.M., Jones D.E., Bassendine M.F., and James O.F. Natural history of early primary biliary cirrhosis. Lancet 348 (1996) 1399-1402
14. Prince M.I., Chetwynd A., Craig W.L., Metcalf J.V., and James O.F. Asymptomatic primary biliary cirrhosis: clinical features, prognosis, and symptom progression in a large population based cohort. Gut 53 (2004) 865-870
15. Milkiewicz P., and Heathcote E.J. Fatigue in chronic cholestasis. Gut 53 (2004) 475-477